These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 33183580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages.
    Vieira ACC, Chaves LL, Pinheiro M, Lima SAC, Ferreira D, Sarmento B, Reis S.
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):653-663. PubMed ID: 29433346
    [Abstract] [Full Text] [Related]

  • 8. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
    Singh H, Jindal S, Singh M, Sharma G, Kaur IP.
    Int J Pharm; 2015 May 15; 485(1-2):138-51. PubMed ID: 25769294
    [Abstract] [Full Text] [Related]

  • 9. Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
    Sohaib M, Shah SU, Shah KU, Shah KU, Khan NR, Irfan MM, Niazi ZR, Alqahtani AA, Alasiri A, Walbi IA, Mahmood S.
    Biomed Res Int; 2022 May 15; 2022():7792180. PubMed ID: 35971450
    [Abstract] [Full Text] [Related]

  • 10. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
    Song X, Lin Q, Guo L, Fu Y, Han J, Ke H, Sun X, Gong T, Zhang Z.
    Pharm Res; 2015 May 15; 32(5):1741-51. PubMed ID: 25407545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
    Shi LL, Lu J, Cao Y, Liu JY, Zhang XX, Zhang H, Cui JH, Cao QR.
    Drug Dev Ind Pharm; 2017 May 15; 43(5):839-846. PubMed ID: 27487431
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study.
    El-Gizawy SA, El-Maghraby GM, Hedaya AA.
    Pharm Dev Technol; 2019 Dec 15; 24(10):1299-1307. PubMed ID: 31507245
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation.
    Piazzini V, Cinci L, D'Ambrosio M, Luceri C, Bilia AR, Bergonzi MC.
    Curr Drug Deliv; 2019 Dec 15; 16(2):142-152. PubMed ID: 30306869
    [Abstract] [Full Text] [Related]

  • 18. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
    Nimje N, Agarwal A, Saraogi GK, Lariya N, Rai G, Agrawal H, Agrawal GP.
    J Drug Target; 2009 Dec 15; 17(10):777-87. PubMed ID: 19938949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preparation, optimization, and in-vitro characterization of α-tocopherol-loaded solid lipid nanoparticles (SLNs).
    Nasiri F, Faghfouri L, Hamidi M.
    Drug Dev Ind Pharm; 2020 Jan 15; 46(1):159-171. PubMed ID: 31894713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.